Parisha Healthcare

Parisha Healthcare Private Limited is an active private pharmaceutical company based in Lucknow, Uttar Pradesh, India, with operations extending to Vadodara, Gujarat. Established in 2020, the company focuses on the manufacturing, marketing, and wholesale trading of a wide range of pharmaceutical formulations, including allopathic medicines, nutraceuticals, and herbal products. Its commercial portfolio features various generic small molecule therapies targeting chronic conditions such as type 2 diabetes, hypertension, cardiovascular diseases, and gastrointestinal disorders. Key products in its lineup include Pari Pio (pioglitazone), Pari Tel Met (telmisartan + metoprolol), Pari Stat (rosuvastatin), and Pepan-DSR (pantoprazole + domperidone).